RxDoctor Payments Data

Dollie Harrilal

Nurse Practitioner · Atlantis, FLNPI 1134164429

Payments from drug & device makers

$4,626in general payments, 2019–2025

Across 145 payments — averaging $31.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$608
  • Biosense Webster, Inc.$588
  • Actelion Pharmaceuticals US, Inc.$369
  • Novartis$330
  • AstraZeneca$320
  • Medtronic$302
  • plus $2K from 19 others

What the payments were for

  • Food & beverage$4,626100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,626 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
VyndamaxTafamidis78$2,105,054
VyndaqelTafamidis Meglumine13$290,320
EntrestoSacubitril/Valsartan119$126,294
EliquisApixaban44$49,975
JardianceEmpagliflozin27$31,698
FarxigaDapagliflozin Propanediol30$23,061
Bumetanide30$1,310
Spironolactone102$976
Metoprolol Succinate58$852
Torsemide30$562
ClopidogrelClopidogrel Bisulfate12$434
Amiodarone Hcl28$411
Atorvastatin Calcium44$343
Digoxin14$338
Carvedilol45$264

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerVyndamax, Vyndaqel, Eliquis$159$2,445,349135 claims
NovartisEntresto$330$126,294119 claims
Boehringer IngelheimJardiance$217$31,69827 claims
AstraZenecaFarxiga$320$23,06130 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in Atlantis

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →